Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)

被引：0

作者：

A J Gross

M Busse

J Leonard

H Schumacher

机构：

[1] Marien Krankenhaus,

[2] Boehringer Ingelheim Pharma GmbH & Co. KG,undefined

来源：

Prostate Cancer and Prostatic Diseases | 2005年 / 8卷

关键词：

benign prostatic hyperplasia; lower urinary tract symptoms; phytotherapy; tamsulosin; postmarketing surveillance study;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The aim of this observational prospective study was to evaluate the switch from phytotherapy to tamsulosin 0.4 mg once daily (o.d.) on efficacy, sexual function and tolerability in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) who have a poor response to at least 4 weeks of phytotherapy. The switch to tamsulosin 0.4 mg o.d. improves LUTS and related quality of life. Sexual function is also slightly improved. Tamsulosin is as well tolerated as phytotherapy and abnormal ejaculation appears to be no problem. Tamsulosin is perceived by both patients and urologists to be superior to preceding phytotherapy.

引用

页码：210 / 214

页数：4

共 50 条

[1] Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
Gross, AJ
Busse, M
Leonard, J
Schumacher, H
PROSTATE CANCER AND PROSTATIC DISEASES, 2005, 8 (03) : 210 - 214
[2] Nocturia in Spanish patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
Hernandez, Carlos
Estivill, Eduard
Prieto, Marta
Badia, Xavier
CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (04) : 1033 - 1038
[3] Interventional therapies for lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH)
Seitz, M.
Bader, M.
Tilki, D.
Stief, C.
Gratzke, C.
MINERVA UROLOGICA E NEFROLOGICA, 2012, 64 (02) : 123 - 133
[4] The impact of treatment on lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) progression
Berges, R
EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (04) : 12 - 17
[5] Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?
Speakman, Mark J.
EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (11) : 680 - 689
[6] Lower urinary tract symptoms/benign prostatic hyperplasia improve considerably after switch from phytotherapy to tamsulosin
Gross, AJ
Busse, M
Leonard, J
Schumacher, H
JOURNAL OF UROLOGY, 2004, 171 (04): : 355 - 356
[7] Male Lower Urinary Tract Symptoms (LUTS) and Benign Prostatic Hyperplasia (BPH)
Roehrborn, Claus G.
MEDICAL CLINICS OF NORTH AMERICA, 2011, 95 (01) : 87 - +
[8] Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK
Speakman, Mark
Kirby, Roger
Doyle, Scott
Ioannou, Chris
BJU INTERNATIONAL, 2015, 115 (04) : 508 - 519
[9] Patient risk profiles for progression of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
Lowe, FC
EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (04) : 7 - 11
[10] The oral controlled absorption system (OCAS®):: The evolution of tamsulosin for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
Chapple, CR
EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (07) : 20 - 22

← 1 2 3 4 5 →